Skip to main content
Premium Trial:

Request an Annual Quote

Millennium Patents Drug Discovery Target Identification Method

Premium

CAMBRIDGE, Mass.-- Millennium Pharmaceuticals has been granted US Patent No. 5,756,305 for a process for identifying genes essential for a pathogen's survival.

"Over the past few years, a growing problem has been identified: bacteria, fungi and other pathogens have developed resistance to current treatments," said Robert Tepper, Millennium's chief scientific officer, pharmaceuticals. "Consequently, there is a growing need for new compounds with novel mechanisms of action. We believe that the process covered by this patent will lead to the discovery and development of drugs that actually kill the pathogens in question, in contrast to many existing therapeutics which merely ameliorate the symptoms of the pathogenic disease or slow the growth of the pathogenic organism."

"This patent covers a methodology for identifying targets for therapeutic intervention that we believe will lead to the development of new and more effective antifungal, antibacterial, and antiparasitic agents," said Mark Boshar, associate general counsel and chief patent counsel at Millennium. "The issuance of this patent highlights the diversity of Millennium's growing patent portfolio. In addition to seeking protection for novel genes, proteins and drug leads, we have been aggressively pursuing patents for innovative process technologies developed in the technology division of the company that we believe are critical to the drug discovery process."

Filed under

The Scan

Missed Early Cases

A retrospective analysis of blood samples suggests early SARS-CoV-2 infections may have been missed in the US, the New York Times reports.

Limited Journal Editor Diversity

A survey finds low diversity among scientific and medical journal editors, according to The Scientist.

How Much of a Threat?

Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned.

PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs

In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.